|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Blood, 1 February 2006, Vol. 107, No. 3, pp. 853-854.
Lymphangiogenesis in vitroUNIVERSITY OF TECHNOLOGY DRESDEN
Research on lymphatic vasculature development has made exciting progress over the past years, yet suitable in vitro systems to study the formation of the lymphatic endothelium were unavailable. Now, Liersch and colleagues report that lymphatic endothelial cells differentiate in mouse embryonic stem cell-derived embryoid bodies.
The embryonic development of the lymphatic vasculature was described by Florence Sabin as early as 1902.1 However, until recently, the molecular mechanisms involved remained elusive. Progress in the field awaited the discovery of molecular markers for lymphatic endothelial cells, notably the vascular endothelial growth factor receptor-3 (VEGFR-3), the transcription factor prospero-related homeobox 1 (Prox-1), and the lymphatic vessel hyaluronan receptor 1 (LYVE-1) (for review, see Hong et al2 and Oliver and Alitalo3). Genetic studies performed in mouse embryos revealed that the expression of Prox-1 in a subpopulation of endothelial cells in the anterior cardinal vein, and their subsequent stimulation by VEGF-C, is required for the subsequent budding and sprouting of lymphatic vessels. A number of additional factors were implicated in lymphangiogenesis; not surprisingly, several of them are also involved in blood-vessel angiogenesis.2,3
Although it is now possible to isolate lymphatic endothelial cells, in vitro systems to study their development were lacking. Embryonic stem (ES) cells are extremely useful to study cellular differentiation processes involved in early-stage organ development because they have the amazing potential to differentiate into a variety of different cell types in vitro, including the cellular constituents of the cardiovascular system.4 Such experiments were instrumental for studying the differentiation of blood-vessel endothelial cells from mesodermal progenitors. In this issue of Blood, Liersch and colleagues report the induction of lymphatic endothelial-cell differentiation in ES cell-derived embryoid bodies. These cells were positive for the panendothelial marker CD31/PECAM-1 and the lymphatic endothelial markers Prox-1 and LYVE-1 (see figure), but negative for the blood vascular marker MECA-32. Lymphatic vessels frequently sprouted from blood-vessel structures, consistent with the in vivo observations. Of interest, the addition of certain growth factors known to induce lymphangiogenesis in vivo revealed significant differences in their potential to promote lymphatic endothelial-cell differentiation in vitro: VEGF-C, and, to a lesser extent, VEGF-A, promoted lymphatic vessel formation, whereas basic fibroblast growth factor did not. Whether these differences indicate that lymphangiogenesis in vivo involved indirect effects, or simply reflect limitations of the in vitro system, remains to be clarified.
One interesting question that is not addressed by the study is whether lymphatic endothelium forms solely by sprouting from blood-vessel endothelium, or whether it differentiates also de novo from endothelial progenitor cells, as blood-vessel endothelium does. In other words, is (lymph-) vasculogenesis involved in lymph vessel formation? The authors plan to address this question in the future by time-lapse studies. Thus, the availability of an in vitro system for studying the differentiation of lymphatic endothelium is a major step toward the elucidation of the molecular events that govern the formation of the lymphatic vasculature. References
  CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
